40
Participants
Start Date
November 2, 2021
Primary Completion Date
November 30, 2026
Study Completion Date
November 30, 2028
MDMA
80mg, 120mg, Placebo
RECRUITING
Stanford Psychiatry and Behavioral Sciences Department, Palo Alto
Collaborators (1)
National Institute on Drug Abuse (NIDA)
NIH
Lykos Therapeutics
INDUSTRY
Stanford University
OTHER